Target intelligence / Profile preview

Immunoglobulin lambda variable 41-1 (IGLVVII-41-1)

Target
IGLVVII-41-1
Molecular classification
Pseudogene, Immunoglobulin variable region gene segment
01

Overview

Immunoglobulin lambda variable 41-1 (IGLVVII-41-1) is a pseudogene belonging to the immunoglobulin lambda variable region in humans.[4][5] The human immunoglobulin lambda locus encodes lambda light chains for immunoglobulins (antibodies) through diverse recombination of variable (V), joining (J), and constant (C) gene segments[1][2][6]. Pseudogenes such as IGLVVII-41-1 are remnant gene segments that have lost their ability to encode functional proteins due to accumulated mutations or deletions. They do not contribute to antibody diversity or function, nor are they involved in disease processes, drug interactions, or therapeutic mechanisms[4][5][6]. Their presence, however, reflects the evolutionary dynamics and allelic diversity of the immunoglobulin gene clusters[2][6]. Key points: - The gene is a non-functional pseudogene within the immunoglobulin lambda locus[4][5][6]. - It is not a drug target, not a receptor, and has no therapeutic or diagnostic application. - "Immunoglobulin lambda variable 41-1" should not be considered a receptor or any other functional protein. - There are no known drugs, mechanisms, biomarkers, or safety concerns associated with it. If you intend to study functional immunoglobulin lambda chains, review entries for fully functional variable region genes or the general immunoglobulin lambda chain, not pseudogenes like IGLVVII-41-1.

Other names
IGLVVII-41-1IGLV(VII)-41-1lambdavg1

Beyond the preview

Go deeper on Immunoglobulin lambda variable 41-1 (IGLVVII-41-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 41-1 (IGLVVII-41-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call